CAP TODAY Pathology/Laboratory Medicine/Laboratory Management
April 2015—The diagnostics division of Siemens Healthcare has announced the U.S. availability of its Advia Centaur Syphilis assay to be used as a diagnostic aid. The assay, which allows for sensitive and specific detection of antibodies to the proteins of Treponema pallidum in human serum or plasma (EDTA, lithium or sodium heparinized, sodium citrate), is available on the company’s Advia Centaur, Centaur XP, and Centaur CP immunoassay systems. It is not intended for blood and tissue donor screening.
The assay is aimed at reducing turnaround time, with results delivered in approximately 29 minutes on the Centaur and Centaur XP systems and approximately 26 minutes on the Centaur CP systems.
Siemens Healthcare , 914-524-2844